{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:08:21Z","timestamp":1793138901975,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Swedish Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","exphem.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.exphem.2024.104217","type":"journal-article","created":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T02:55:33Z","timestamp":1713668133000},"page":"104217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Of gains and losses: SAMD9\/SAMD9L and monosomy 7 in myelodysplastic syndrome"],"prefix":"10.1016","volume":"134","author":[{"given":"J\u00f6rg","family":"Cammenga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2024.104217_bib0001","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1182\/blood-2017-12-822262","article-title":"The enigma of monosomy 7","volume":"131","author":"Inaba","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104217_bib0002","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1038\/s41375-023-02003-x","article-title":"Genomics of deletion 7 and 7q in myeloid neoplasm: from pathogenic culprits to potential synthetic lethal therapeutic targets","volume":"37","author":"Mori","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2024.104217_bib0003","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1365-2141.2007.06958.x","article-title":"Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia: molecular classification and treatment options","volume":"140","author":"Niemeyer","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2024.104217_bib0004","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/blood-2011-06-360313","article-title":"Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency","volume":"118","author":"Dickinson","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104217_bib0005","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/ng.913","article-title":"Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia","volume":"43","author":"Hahn","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2024.104217_bib0006","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1182\/blood-2011-05-356352","article-title":"Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome","volume":"118","author":"Hsu","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104217_bib0007","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/ng.923","article-title":"Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome)","volume":"43","author":"Ostergaard","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2024.104217_bib0008","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1182\/blood-2015-09-669937","article-title":"Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents","volume":"127","author":"Wlodarski","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104217_bib0009","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/0002-9343(78)90744-1","article-title":"A family with acute leukemia, hypoplastic anemia and cerebellar ataxia: association with bone marrow C-monosomy","volume":"65","author":"Li","year":"1978","journal-title":"Am J Med"},{"key":"10.1016\/j.exphem.2024.104217_bib0010","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0165-4608(81)90013-3","article-title":"Ataxia-pancytopenia: syndrome of cerebellar ataxia, hypoplastic anemia, monosomy 7, and acute myelogenous leukemia","volume":"4","author":"Li","year":"1981","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.exphem.2024.104217_bib0011","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1172\/JCI114262","article-title":"Familial bone marrow monosomy 7. Evidence that the predisposing locus is not on the long arm of chromosome 7","volume":"84","author":"Shannon","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2024.104217_bib0012","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.ajhg.2016.04.009","article-title":"Ataxia-pancytopenia syndrome is caused by missense mutations in SAMD9L","volume":"98","author":"Chen","year":"2016","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.exphem.2024.104217_bib0013","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1172\/JCI91913","article-title":"Somatic mutations and progressive monosomy modify SAMD9-related phenotypes in humans","volume":"127","author":"Buonocore","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2024.104217_bib0014","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/ng.3569","article-title":"SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome, and are associated with loss of chromosome 7","volume":"48","author":"Narumi","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2024.104217_bib0015","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1038\/leu.2017.142","article-title":"Germline SAMD9 mutation in siblings with monosomy 7 and myelodysplastic syndrome","volume":"31","author":"Schwartz","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2024.104217_bib0016","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1182\/blood-2017-09-806489","article-title":"A landscape of germ line mutations in a cohort of inherited bone marrow failure patients","volume":"131","author":"Bluteau","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104217_bib0017","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1038\/s41467-017-01590-5","article-title":"The genomic landscape of pediatric myelodysplastic syndromes","volume":"8","author":"Schwartz","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.exphem.2024.104217_bib0018","doi-asserted-by":"crossref","first-page":"e318","DOI":"10.3324\/haematol.2018.207316","article-title":"A novel germline SAMD9L mutation in a family with ataxia-pancytopenia syndrome and pediatric acute lymphoblastic leukemia","volume":"104","author":"Cheah","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2024.104217_bib0019","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/bjh.17006","article-title":"Prevalence of germline GATA2 and SAMD9\/9L variants in paediatric haematological disorders with monosomy 7","volume":"191","author":"Yoshida","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2024.104217_bib0020","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/s41576-019-0139-x","article-title":"Somatic genetic rescue in Mendelian haematopoietic diseases","volume":"20","author":"Revy","year":"2019","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.exphem.2024.104217_bib0021","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1182\/blood-2016-10-743302","article-title":"Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms","volume":"129","author":"Tesi","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104217_bib0022","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1038\/s41591-021-01511-6","article-title":"Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9\/SAMD9L syndromes","volume":"27","author":"Sahoo","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2024.104217_bib0023","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3324\/haematol.2017.180778","article-title":"Constitutional SAMD9L mutations cause familial myelodysplastic syndrome and transient monosomy 7","volume":"103","author":"Pastor","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2024.104217_bib0024","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nbt.3178","article-title":"Functional analysis of a chromosomal deletion associated with myelodysplastic syndromes using isogenic human induced pluripotent stem cells","volume":"33","author":"Kotini","year":"2015","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.exphem.2024.104217_bib0025","article-title":"Therapeutic discovery for marrow failure with MDS predisposition using pluripotent stem cells","volume":"5","author":"Ruiz-Gutierrez","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.exphem.2024.104217_bib0026","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1212\/NXG.0000000000000183","article-title":"Ataxia-pancytopenia syndrome with SAMD9L mutations","volume":"3","author":"Gorcenco","year":"2017","journal-title":"Neurol Genet"},{"key":"10.1016\/j.exphem.2024.104217_bib0027","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1111\/bjh.16322","article-title":"In trans early mosaic mutational escape and novel phenotypic features of germline SAMD9 mutation","volume":"188","author":"Hockings","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2024.104217_bib0028","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3389\/fendo.2019.00625","article-title":"Reversion SAMD9 mutations modifying phenotypic expression of MIRAGE syndrome and allowing inheritance in a usually de novo disorder","volume":"10","author":"Roucher-Boulez","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.exphem.2024.104217_bib0029","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1172\/JCI129301","article-title":"Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases","volume":"130","author":"de Jesus","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2024.104217_bib0030","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1182\/blood-2017-05-787390","article-title":"Germline loss-of-function SAMD9 and SAMD9L alterations in adult myelodysplastic syndromes","volume":"132","author":"Nagata","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104217_bib0031","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1182\/blood.2022019304","article-title":"Prevalence and clinical expression of germ line predisposition to myeloid neoplasms in adults with marrow hypocellularity","volume":"142","author":"Molteni","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104217_bib0032","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ccr.2013.08.011","article-title":"Haploinsufficiency of SAMD9L, an endosome fusion facilitator, causes myeloid malignancies in mice mimicking human diseases with monosomy 7","volume":"24","author":"Nagamachi","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2024.104217_bib0033","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bbrc.2009.04.004","article-title":"Identification of a common microdeletion cluster in 7q21.3 subband among patients with myeloid leukemia and myelodysplastic syndrome","volume":"383","author":"Asou","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.exphem.2024.104217_bib0034","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.exphem.2024.104217_bib0035","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1182\/bloodadvances.2019000644","article-title":"ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants","volume":"3","author":"Luo","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.exphem.2024.104217_bib0036","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1182\/blood.2023020209","article-title":"Prevalence and significance of DDX41 gene variants in the general population","volume":"142","author":"Cheloor Kovilakam","year":"2023","journal-title":"Blood"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X24000766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X24000766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T13:05:42Z","timestamp":1717506342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X24000766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":36,"alternative-id":["S0301472X24000766"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2024.104217","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Of gains and losses: SAMD9\/SAMD9L and monosomy 7 in myelodysplastic syndrome","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2024.104217","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society for Experimental Hematology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104217"}}